![Robert G. L. Shorr](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Robert G. L. Shorr
Gründer bei Cornerstone Pharmaceuticals, Inc.
Aktive Positionen von Robert G. L. Shorr
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Cornerstone Pharmaceuticals, Inc.
![]() Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Direktor/Vorstandsmitglied | - | - |
Technik-/Wissenschafts-/F&E-Leiter | - | - | |
Gründer | - | - | |
Vorstandsvorsitzender | 01.01.2000 | 10.10.2014 | |
Stony Brook University | Corporate Officer/Principal | 01.01.1998 | - |
Tissue Engineering Charities, Inc. | Direktor/Vorstandsmitglied | 16.05.2011 | - |
Imperial College London | Direktor/Vorstandsmitglied | 01.01.1999 | - |
Karriereverlauf von Robert G. L. Shorr
Ehemalige bekannte Positionen von Robert G. L. Shorr
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
BRAINSTORM CELL THERAPEUTICS INC. | Direktor/Vorstandsmitglied | 31.03.2005 | 01.02.2018 |
BIODELIVERY SCIENCES INTERNATIONAL, INC. | Direktor/Vorstandsmitglied | - | 28.04.2005 |
UNITED THERAPEUTICS CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 | 01.01.2005 |
Smithkline & French Laboratories US, Inc. | Corporate Officer/Principal | 01.01.1988 | 01.01.1988 |
AT Biochem, Inc. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Gründer | 07.05.2010 | - | |
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | - | - |
Ausbildung von Robert G. L. Shorr
University of London | Doctorate Degree |
State University of New York at Buffalo | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 10 |
Vereinigtes Königreich | 4 |
Operativ
Director/Board Member | 5 |
Chief Tech/Sci/R&D Officer | 4 |
Founder | 2 |
Sektoral
Health Technology | 5 |
Consumer Services | 5 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
ENZON PHARMACEUTICALS, INC. | Health Technology |
UNITED THERAPEUTICS CORPORATION | Health Technology |
Private Unternehmen | 5 |
---|---|
BioDelivery Sciences International, Inc.
![]() BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Cornerstone Pharmaceuticals, Inc.
![]() Cornerstone Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Rafael Pharmaceuticals, Inc. develops anti-cancer drug delivery technology. It produces highly selective and effective anti-cancer agents with minimal toxic effects on normal cells and tissues by attacking regulatory processes that are unique to cancer and not found in healthy cells. The firm would ensure a significant improvement in the safety profile of cancer treatment. The firm provides CPI-613, Altered Energy Metabolism Directed (AEMD) platform, targets enzymes that are involved in cancer cell energy metabolism and are located in the mitochondria of cancer cells. The company was founded by Robert G. L. Shorr and is headquartered in Cranbury, NJ. | Commercial Services |
AT Biochem, Inc. | |
Tissue Engineering Charities, Inc. | |
Smithkline & French Laboratories US, Inc. |
- Börse
- Insiders
- Robert G. L. Shorr
- Erfahrung